TY  - GEN
AU  - Beghetti,Maurice
AU  - Channick,Richard N
AU  - Chin,Kelly M
AU  - Di Scala,Lilla
AU  - Gaine,Sean
AU  - Ghofrani,Hossein-Ardeschir
AU  - Hoeper,Marius M
AU  - Lang,Irene M
AU  - McLaughlin,Vallerie V
AU  - Preiss,Ralph
AU  - Rubin,Lewis J
AU  - Simonneau,Gérald
AU  - Sitbon,Olivier
AU  - Tapson,Victor F
AU  - Galiè,Nazzareno
TI  - Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study
SN  - 1879-0844
PY  - 2019///1206
KW  - Acetamides
KW  - administration & dosage
KW  - Adult
KW  - Antihypertensive Agents
KW  - Cardiac Surgical Procedures
KW  - adverse effects
KW  - Disease Progression
KW  - Double-Blind Method
KW  - Drug Monitoring
KW  - methods
KW  - Early Medical Intervention
KW  - Female
KW  - Heart Defects, Congenital
KW  - complications
KW  - Humans
KW  - Hypertension, Pulmonary
KW  - diagnosis
KW  - Male
KW  - Middle Aged
KW  - Proportional Hazards Models
KW  - Pyrazines
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/ejhf.1375
ER  -